The Mailer They Couldn't Send
The 2026 West Virginia Senate primaries were sold as a fight over puberty blockers, girls’ sports, and “woke liberals.” The paper trail tells a different story: a fight over coal dust, black lung, 340B medicine, rural clinics, and who would control the State Senate when those issues came back to the Capitol.
If the people who spent millions reshaping the West Virginia Senate had been honest, the mailer attacking Tom Takubo would have looked something like this:
Tom Takubo knows too much about what coal dust does to a miner’s lungs.
He also sponsored a law making it harder for drug manufacturers to squeeze the safety-net hospitals, rural clinics, and contract pharmacies that serve miners after the dust has already done its work.
We need him out of Senate leadership before the next fights over silica, black lung, 340B drug pricing, and rural health care.
That would have been the honest mailer.
It also would not have polled very well.
So West Virginia voters got something else.
The Culture War is Useful Because Black Lung Does Not Fit on a Mailer
The 2026 Republican Senate primaries were presented to voters as a referendum on transgender athletes, puberty blockers, DEI, and whether West Virginia had become insufficiently angry at people who do not look, pray, live, or vote exactly like the consultants designing the mail pieces.
That was the public case.
The documentary record shows a parallel political project: preserve Senate control for Randy Smith, defeat Tom Takubo and the legislators aligned with him, and remake the Senate leadership coalition before the next fights over coal regulation, occupational disease, rural health financing, and drug manufacturers’ power reached Charleston.
The West Virginia Coal Association and major coal companies did not sit out this leadership contest.
In July 2025, WVCA President Chris Hamilton asked coal-industry members to support a “Business Roundtable and Fundraising Reception” for Senate President Randy Smith and to write checks to the Mountaineer Conservative Coalition, Inc., the leadership-aligned 501(c)(4) organization. The invitation warned of a “formidable challenge” to Smith’s leadership and urged supporters to give him the “political support and wherewithal” to prevail in 2026 and retain control of the State Senate. It recommended $25,000 contributions and expressly stated that there was no maximum donation and that company checks could be accepted.
For industries accustomed to defining the terms of debates about coal, safety, health care, and regulation, it can be inconvenient for a Pulmonologist to hold a Senate leadership position.
Black Lung Is Back
Black lung is not a historical artifact from grainy photographs and old United Mine Workers posters.
It is back.
Federal surveillance and public-health reporting show that coal workers’ pneumoconiosis has resurged in central Appalachia at levels not seen in nearly half a century. Roughly one in three veteran underground miners in the region has evidence of black lung on chest X-ray. The severe, disabling form of the disease—progressive massive fibrosis—is increasingly appearing in younger miners and after fewer years underground than previous generations of miners experienced.
The central culprit is respirable crystalline silica: tiny particles of rock dust created as modern mining operations cut through thinner seams of coal and increasing amounts of sandstone and surrounding rock.
Silica does not care whether a campaign consultant calls you conservative.
It does not care whether a legislator puts a “Friends of Coal” logo on a podium.
It does not care how many glossy mailers show a candidate in a hard hat.
Silica enters a miner’s lungs. The body cannot clear it. The lungs scar. The scarring progresses. Eventually, the patient may be left fighting for air with tissue that no longer functions the way a lung is supposed to function.
That is the disease a pulmonologist understands.
That is the disease a coal-miner’s son has heard in his own home.
And that is why a lung doctor with leadership power is not merely a political rival. He is a person capable of making the industry answer questions it prefers not to hear.
The coal industry does not deny that silica is dangerous.
It does something more sophisticated.
It accepts the premise and fights over implementation.
In its September 2023, comments on MSHA’s AB36 silica proposal, the West Virginia Coal Association supported lowering the permissible silica exposure limit. But it also urged the agency to adopt measurement and enforcement choices that would give operators more flexibility and narrow the universe of enforceable violations.
The WVCA pressed MSHA to:
* Maintain coal-dust sampling at 2.0 liters per minute instead of the agency’s proposed 1.7 liters per minute.
* Use actual minutes worked rather than an eight-hour time-weighted average.
* Apply error factors that could reduce which readings qualify as violations.
* Permit the full “hierarchy of controls,” including administrative measures and personal protective equipment, instead of placing primary emphasis on engineering controls that remove or reduce dust at its source.
This is where the culture-war conversation becomes absurd.
A respirator is not a ventilation system.
A respirator does not remove silica from the mine.
A respirator does not change the cutting method, reduce dust generation, improve water sprays, improve enclosure, improve ventilation, or change the engineering conditions that put the dust in the air.
A respirator puts more of the burden on the worker who has to wear it correctly, maintain it correctly, fit it correctly, keep it on through a shift, and hope the system around him does not fail.
That is not a technical distinction. It is the difference between prevention and containment.
The difference between keeping dust out of a lung and telling the miner to manage the dust once it is already there.
And that is why a pulmonologist in Senate leadership matters.
Because he knows exactly what “flexibility” means when it is written into a dust rule.
It means somebody else will eventually have to breathe the consequences.
Care after the Dust has Done Its Damage. This is Where 340B Enters the Picture
The federal 340B Drug Pricing Program allows eligible safety-net providers to obtain outpatient medicines at discounted prices. HRSA identifies Black Lung Clinics as eligible specialty clinics and explains that they may use 340B savings to improve and expand care for miners with coal mine dust lung disease.
That matters because Black Lung Clinics are not theoretical institutions.
In West Virginia, the Black Lung Clinics Program lists care sites in communities including Man, Logan, Delbarton, Gilbert, Madison, Dawes, Whitesville, Oceana, Harts, Kermit, Gary, Northfork, Scarbro, Sophia, Princeton, Rainelle, Meadow Bridge, Alderson, Maxwelton, and White Sulphur Springs.
The network includes providers such as Southern WV Health System, Valley Health Systems, Boone Memorial Hospital, Cabin Creek Health Systems, Tug River Health Association, Raleigh‑Boone Medical Center, Bluestone Health Association, Rainelle Medical Center, and others serving coalfield communities.
These clinics provide:
* Pulmonary and respiratory care.
* Lung-function testing.
* Chest imaging.
* Medical case management.
* Patient education and outreach.
* Pulmonary rehabilitation.
* Black-lung examinations.
* Federal and state benefits counseling.
The federal program says those services are available regardless of a miner’s ability to pay.
That sentence is the whole story.
Regardless of ability to pay.
That is not a “hospital monopoly.”
That is not a “medical fiefdom.”
That is the rescue system after the mine, the insurance company, the job market, and the body have all failed a worker at once.
And 340B is part of how that rescue system stretches scarce resources further.
How to Miner Health Protections Connect to 340b
In 2024, Tom Takubo was the lead sponsor of Senate Bill 325, formally titled “Relating to distribution of drugs to safety net providers and contract pharmacies.”
The technical name hides a plain purpose.
SB 325 sought to stop manufacturers, wholesalers, and their affiliates from denying, restricting, prohibiting, or interfering with the acquisition and delivery of 340B-discounted drugs to eligible safety-net providers and their contract pharmacies. The law provided for state enforcement and civil penalties of up to $50,000 per violation.
A contract pharmacy is not a loophole.
For a rural clinic, a hospital, or a Black Lung Clinics Program provider, it can be the practical bridge between the discounted medicine and the patient who lives miles away from the nearest provider-owned pharmacy.
That is especially true in the coalfields.
In a rural county, “go somewhere else” does not mean crossing the street. It can mean borrowing a car. Taking off work. Paying for gasoline. Finding somebody to drive. Missing a day of care. Postponing a refill. Going without the medication until the next check comes.
SB 325 was West Virginia’s attempt to stop pharmaceutical manufacturers from making that bridge harder to cross.
For miners and rural patients, it was a medicine-access law.
For safety-net providers, it was a financial-protection law.
For drug manufacturers, it was a state-level precedent they did not want to spread.
And for a coal-miner’s-son pulmonologist with Senate power, it was proof that he was willing to use that power.
That is strike one.
The Drug Companies Knew Exactly What Was At Stake
PhRMA, the national trade association representing major pharmaceutical companies, sued West Virginia over SB 325. Novartis and AbbVie brought parallel challenges. The industry argued that the state’s contract-pharmacy protections were preempted by federal 340B law.
The legal argument was couched in the language of federal supremacy, claims data, duplicate discounts, diversion, and regulatory authority.
But the real-world issue is simple.
When a manufacturer restricts the ability of a safety-net provider to use contract pharmacies, it reduces the provider’s flexibility in getting discounted drugs to patients.
The burden does not disappear.
* It moves.
* It moves to the rural hospital.
* It moves to the community health center.
* It moves to the contract pharmacy.
* It moves to the Black Lung Clinic.
It moves to the miner whose lungs are already compromised and whose budget does not have room for pharmaceutical-industry pricing power.
At the same time, federal lobbying disclosures show that Capitol Counsel LLC—the Washington lobbying firm in which First Lady Denise Henry Morrisey held an ownership interest—was paid by PhRMA to lobby on the “340B Drug Program” and to monitor implementation of the 340B Prescription Drug Discount Program.
The filings compiled in the public record show Capitol Counsel reporting approximately $2.04 million in PhRMA lobbying income from the fourth quarter of 2019 through the second quarter of 2025.
Capitol Counsel’s health-sector client work also included companies such as Genentech, Sanofi, AstraZeneca, and Biogen—major manufacturers with clear interests in drug pricing, distribution, and the broader 340B policy fight.
The point is not that Denise Morrisey personally handled every one of those matters. The public records do not establish that.
The point is that the firm in which the First Lady held an interest was being paid by PhRMA to lobby on 340B while PhRMA and major manufacturers were using federal courts to challenge state laws like West Virginia’s SB 325.
That is not conjecture.
That is the filing record.
Americans for Prosperity’s “hospital cartel” Points at the Wrong Target
This is where Jason Huffman’s “hospital cartel” rhetoric becomes more than insulting.
It becomes useful cover.
AFP‑WV says Certificate of Need laws allow hospital CEOs to protect “medical fiefdoms,” operate “government-run health care monopolies,” collude with regulators, and veto competition.
There are legitimate questions to ask about hospital consolidation, executive pay, billing, market concentration, and Certificate of Need. West Virginians should ask them. Rural health care is too important to exempt any institution from scrutiny.
But that is not what Huffman’s slogan does.
It takes a complex health-care system and turns the people trying to keep it functioning into the villain.
It tells voters to be angry at the rural hospital.
It tells them to be angry at the community clinic.
It tells them to be angry at the contract pharmacy.
It tells them to be angry at the pulmonologist.
It tells them to be angry at the same safety-net network that provides lung tests, imaging, rehabilitation, benefits counseling, and treatment support to miners who cannot afford to pay cash.
Meanwhile, the truly national power centers remain off the postcard.
The pharmaceutical manufacturers setting drug prices do not appear.
The trade association litigating against state 340B protections does not appear.
The Washington lobbyists collecting millions to shape federal drug-policy debates do not appear.
The coal trade association raising unlimited corporate money to preserve a preferred Senate leadership structure does not appear.
The actual players with the money to buy influence across states, litigate in multiple federal courts, and shape the rules under which miners receive care do not appear.
Instead, voters are invited to blame the clinic.
That is not an accident.
It is the whole strategy.
The Real Cartel Is The Political Machine
If “cartel” means a network of separate entities that act in concert, share an objective, move money through multiple vehicles, preserve the appearance of independence, and attempt to control an outcome that each member could not control alone, then West Virginians ought to look much harder at the political machine that lectured them about hospital monopolies.
Mountaineer Conservative Coalition and Mountaineer Conservative Action did not run a campaign about silica.
They did not run a campaign about black lung.
They did not run a campaign about 340B.
They did not explain the policy implications of SB 325.
They did not tell voters that a coal-miner’s-son pulmonologist sponsored a law that protected rural safety-net providers from pharmaceutical-manufacturer restrictions.
They ran culture-war attacks.
They accused Takubo of endangering children. They used puberty blockers, girls’ sports, and “woke” politics to turn a physician who treats miners’ lungs into a political hazard.
Then the Senate Caucus Committee’s own materials celebrated the outcome as “Team Randy” defeating “Team Takubo.”
That is not a single-issue campaign.
That is a leadership purge.
And it makes sense only when you ask what kind of leader Tom Takubo was positioned to be.
He was a politician who could understand the difference between engineering controls and a respirator.
He was a physician who could translate black-lung data into human terms.
He was a coal miner’s son who knew that “Friends of Coal” and “friends of miners” are not always the same thing.
He was a sponsor of SB 325, a law that chose safety-net clinics and rural patients over pharmaceutical restrictions.
He was a Senate leader.
For the coal companies and drug manufacturers whose interests repeatedly collide with strong dust protections and strong rural-health protections, that combination was not abstract.
It was a problem.
The Culture War was The Cover Story
The documentary record does not prove illegal coordination among every campaign, PAC, nonprofit, company, consultant, and donor involved in the 2026 primaries.
It does not prove that every entity met in one room and designed one master plan.
The independent-expenditure filings say the expenditures were not authorized by candidates or candidate committees. West Virginia law recognizes independent expenditures as a legal category.
But legality and motive are different questions.
The question is not whether every organization was legally independent on paper.
The question is what the money was built to accomplish.
Line up the evidence:
* A coal trade association and coal companies raised unlimited corporate money for a leadership-aligned 501(c)(4) aimed at preserving Randy Smith’s control of the Senate.
* That leadership network and affiliated political organizations targeted Tom Takubo and candidates aligned with his Senate-presidency effort.
* The public messaging focused on culture-war themes: puberty blockers, transgender athletes, DEI, and supposed threats to children.
* Takubo was a coal-miner’s-son pulmonologist with direct knowledge of black lung and silica disease.
* The West Virginia Coal Association had taken positions in the federal silica-rule debate that favored flexibility, broader use of PPE, and less emphasis on costly source-control engineering measures.
* Takubo sponsored SB 325, a law designed to protect 340B contract-pharmacy access for safety-net providers.
* PhRMA and pharmaceutical manufacturers sued to block that law, while Capitol Counsel was paid by PhRMA to lobby on 340B.
No one needs to believe in a secret meeting to understand the political alignment.
Coal interests benefit from Senate leadership less likely to challenge them on dust and silica.
Pharmaceutical manufacturers benefit from a political environment less willing to protect 340B contract-pharmacy access for rural safety-net providers.
The coalfield clinics and hospitals that care for miners need strong prevention in the mine and strong financial tools after exposure.
And the person sitting at the intersection of all of those interests was a coal-miner’s-son lung doctor with significant Senate power.
The culture-war message was explicit.
The policy stakes were not.
What “Friends Of Coal” Leaves Out
West Virginia’s political class loves the phrase “Friends of Coal.”
It is a powerful brand because it blurs a line that ought to remain visible.
Coal miners are not coal companies.
A miner’s interest is breathable air underground, a fair wage, a safe shift, a healthy retirement, treatment when the job causes disease, and a family that does not spend its final years listening to him fight for air.
A coal company’s interest is production, cost control, regulatory flexibility, liability management, and shareholder return.
Those interests sometimes overlap.
They also sometimes collide directly.
A strong silica rule may cost more money underground.
A weak silica rule may cost more lives aboveground.
A strong 340B contract-pharmacy protection may reduce pharmaceutical manufacturers’ control over the distribution conditions attached to discounted drugs.
A weak protection may reduce the financial flexibility of rural hospitals and clinics trying to serve patients who cannot absorb higher costs.
That is why the real question is not whether a politician wears a hard hat in a campaign photograph.
The question is whether he will support the protections that keep dust out of a miner’s lungs and medicine within reach after the damage is done.
That is the difference between being a friend of coal and being a friend of coal miners.
The People They Called Monopolists are The Rescue System
When a miner with black lung needs help, he does not call a think tank.
He does not call a PAC.
He does not call a pharmaceutical trade association.
He does not call a Washington lobbyist.
He goes to the people AFP wants to call a cartel.
He goes to the hospital.
He goes to the clinic.
He goes to the pulmonary program.
He goes to the respiratory therapist.
He goes to the benefits counselor.
He goes to the contract pharmacy.
He goes to the person who can explain what the test results mean, fill out the forms, find a way to get the medicine, and tell him what happens next.
That is not a monopoly.
That is the rescue system.
It may be imperfect. It may be underfunded. It may be forced to make impossible choices because rural health care is an impossible business model in a state where patients are poor, scattered, sick, and often too far from care.
But it is the system that remains when a miner cannot breathe.
And 340B is one of the tools that helps it remain.
The Question They Cannot Answer
Jason Huffman and AFP‑WV are entitled to argue for repealing Certificate of Need. Voters can judge that argument.
Coal companies are entitled to submit comments on federal regulations. Voters can judge those positions.
Pharmaceutical manufacturers are entitled to litigate federal statutory questions. Courts can decide those cases.
But all of them should answer a question that cannot be hidden behind a mailer about girls’ sports:
When the silica rule is weakened, delayed, or softened, who breathes the dust?
When a rural hospital or Black Lung Clinic loses 340B flexibility, who pays more for the medicine?
When a contract pharmacy becomes harder to use, who drives farther, waits longer, or goes without?
When a coal-miner’s-son pulmonologist is removed from Senate leadership, who loses somebody capable of explaining what the policy debate means inside an actual human lung?
* Not the coal executive.
* Not the pharmaceutical manufacturer.
* Not the Washington lobbyist.
* Not the consultant who wrote the text message.
* The person who loses is the miner.
* The widow.
The child who hears the same sound in the living room that my family heard when my grandfather, Jiggs, struggled to breathe at the end of his life.
That sound is not an abstraction.
* It is not “woke.”
* It is not a political talking point.
* It is not a culture-war wedge.
* It is the cost.
And every West Virginian deserves to know who is trying to move that cost from the people making the profit onto the people who did the work.
Because the real fight was never just about girls’ sports or puberty blockers.
* It was about dust.
* It was about lungs.
* It was about medicine.
It was about who holds the gavel when coal companies and drug manufacturers come asking for flexibility.
And, for miners, the price is still measured in breath.
Jimmy Keady’s May 27th MetroNews Interview
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit wvpolicy.substack.com
